Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine

• Status: Completed
• Trial end date: 2019-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of Bilateral Transversus Abdominis Plane Block with Exparel versus Continuous Epidural Analgesia With Bupivacaine

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Cleveland Clinic
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Written informed consent

• 18-85 years old

• ASA Physical Status 1-3

• Scheduled for elective open or laparoscopic abdominal surgery, including colorectal and hysterectomy surgeries

• Anticipated hospitalization of three nights

• Expected requirement for parenteral opioids for at least 72 hours for postoperative pain

• Able to use IV PCA systems.

Exclusion Criteria:

• Hepatic disease, e.g. twice the normal levels of liver enzymes

• Kidney disease, e.g. twice the normal level of serum creatinine

• Bupivacaine sensitivity or known allergy

• Women who are pregnant or breastfeeding

• Anticoagulants considered to be a contraindication for epidural or TAP blocks.

• Surgeries with high port sites will be excluded